Banque Transatlantique Sa Acadia Pharmaceuticals Inc Call Options Transaction History
Banque Transatlantique Sa
- $5.69 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACAD
# of Institutions
351Shares Held
165MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$942 Million8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$334 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$265 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$188 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$154 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.56B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...